| EP2991507 - COMPOSITION COMPRISING FISH OIL AND JUICE FOR USE IN THE TREATMENT OF CANCER [Right-click to bookmark this link] | |||
| Former [2016/10] | USE OF A COMPOSITION COMPRISING FISH OIL AND JUICE FOR THE TREATMENT AND/OR POST TREATMENT OF CANCER | ||
| [2025/33] | Status | Patent maintained as amended Status updated on 05.12.2025 Database last updated on 11.04.2026 | |
| Former | The patent has been granted Status updated on 05.07.2019 | ||
| Former | Grant of patent is intended Status updated on 27.03.2019 | ||
| Former | Examination is in progress Status updated on 25.05.2018 | Most recent event Tooltip | 05.12.2025 | Patent maintained (B2 publication) | published on 07.01.2026 [2026/02] | Applicant(s) | For all designated states Smartfish AS Gaustadallèen 21 0349 Oslo / NO | [2026/02] |
| Former [2016/10] | For all designated states Smartfish AS Gaustadallèen 21 0349 Oslo / NO | Inventor(s) | 01 /
MATHISEN, Janne Sande c/o Smartfish AS Gaustadallèen 21 N-0349 Oslo / NO | [2016/10] | Representative(s) | Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB | [2026/02] |
| Former [2016/10] | Zacco Norway AS Haakon VII's gate 2 PO Box 2003 Vika 0125 Oslo / NO | Application number, filing date | 14726214.1 | 22.04.2014 | [2016/10] | WO2014NO50061 | Priority number, date | NO20130000552 | 22.04.2013 Original published format: NO 20130552 | [2016/10] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2014175748 | Date: | 30.10.2014 | Language: | EN | [2014/44] | Type: | A1 Application with search report | No.: | EP2991507 | Date: | 09.03.2016 | Language: | EN | The application published by WIPO in one of the EPO official languages on 30.10.2014 takes the place of the publication of the European patent application. | [2016/10] | Type: | B1 Patent specification | No.: | EP2991507 | Date: | 07.08.2019 | Language: | EN | [2019/32] | Type: | B2 New European patent specification | No.: | EP2991507 | Date: | 07.01.2026 | Language: | EN | [2026/02] | Search report(s) | International search report - published on: | EP | 30.10.2014 | Classification | IPC: | A23L5/00, A61K35/00, A23L33/105, A23L33/115, A61K31/202, A61K35/60, A61K36/00, A61K9/00, A61K9/107, A61P35/00 | [2025/33] | CPC: |
A61K31/202 (EP,US);
A23L33/105 (EP,BR,US);
A23L33/115 (EP,BR,US);
A61K35/60 (EP,US);
A61K36/00 (EP,US);
A61K47/36 (US);
A61K9/0095 (EP,US);
A61K9/107 (EP,US);
A61P35/00 (EP);
A23V2002/00 (EP,US)
(-)
| C-Set: |
A61K36/00, A61K2300/00 (US,EP);
A23V2002/00, A23V2200/02, A23V2200/222, A23V2200/308, A23V2250/1868, A23V2250/187, A23V2250/1882, A23V2250/2106 (EP,US) |
| Former IPC [2016/10] | A23L5/00, A61K35/00 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2016/10] | Title | German: | ZUSAMMENSETZUNG MIT FISCHÖL UND SAFT ZUR VERWENDUNG ZUR BEHANDLUNG VON KREBS | [2025/33] | English: | COMPOSITION COMPRISING FISH OIL AND JUICE FOR USE IN THE TREATMENT OF CANCER | [2025/33] | French: | COMPOSITION COMPRENANT DE L'HUILE DE POISSON ET DU JUS POUR L'UTILISATION POUR LE TRAITEMENT DU CANCER | [2025/33] |
| Former [2016/10] | VERWENDUNG EINER ZUSAMMENSETZUNG MIT FISCHÖL UND SAFT ZUR BEHANDLUNG UND/ODER NACHBEHANDLUNG VON KREBS | ||
| Former [2016/10] | USE OF A COMPOSITION COMPRISING FISH OIL AND JUICE FOR THE TREATMENT AND/OR POST TREATMENT OF CANCER | ||
| Former [2016/10] | UTILISATION D'UNE COMPOSITION COMPRENANT DE L'HUILE DE POISSON ET DU JUS POUR LE TRAITEMENT ET/OU LE POST-TRAITEMENT DU CANCER | Entry into regional phase | 20.11.2015 | National basic fee paid | 20.11.2015 | Designation fee(s) paid | 20.11.2015 | Examination fee paid | Examination procedure | 11.02.2015 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 20.11.2015 | Examination requested [2016/10] | 14.06.2016 | Amendment by applicant (claims and/or description) | 25.05.2018 | Despatch of a communication from the examining division (Time limit: M04) | 23.08.2018 | Reply to a communication from the examining division | 14.09.2018 | Despatch of a communication from the examining division (Time limit: M04) | 15.01.2019 | Reply to a communication from the examining division | 05.04.2019 | Communication of intention to grant the patent | 24.06.2019 | Fee for grant paid | 24.06.2019 | Fee for publishing/printing paid | 24.06.2019 | Receipt of the translation of the claim(s) | Opposition(s) | Opponent(s) | 01
22.04.2020
ADMISSIBLE N.V. Nutricia Eerste Stationsstraat 186 2712 HM Zoetermeer / NL Opponent's representative Nederlandsch Octrooibureau P.O. Box 29720 2502 LS The Hague / NL | [2020/22] | 17.06.2020 | Invitation to proprietor to file observations on the notice of opposition | 26.10.2020 | Reply of patent proprietor to notice(s) of opposition | 12.01.2022 | Date of oral proceedings | 10.02.2022 | Despatch of minutes of oral proceedings | 10.02.2022 | Despatch of communication that the patent will be revoked | 28.07.2025 | Despatch of interlocutory decision in opposition | 28.07.2025 | Legal effect of interlocutory decision in opposition | 05.11.2025 | Despatch of communication that the patent will be maintained as amended | Appeal following opposition | 19.04.2022 | Appeal received No. T1057/22 | 19.04.2022 | Payment of appeal fee | 20.06.2022 | Statement of grounds filed | 24.04.2024 | Result of appeal procedure: maintenance in amended form | 22.07.2024 | Despatch of the decision of the Board of Appeal | 24.04.2024 | Date of oral proceedings | Fees paid | Renewal fee | 11.04.2016 | Renewal fee patent year 03 | 10.04.2017 | Renewal fee patent year 04 | 11.04.2018 | Renewal fee patent year 05 | 15.04.2019 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | AL | 07.08.2019 | CY | 07.08.2019 | MC | 07.08.2019 | MK | 07.08.2019 | MT | 07.08.2019 | RO | 07.08.2019 | RS | 07.08.2019 | SM | 07.08.2019 | TR | 07.08.2019 | IS | 07.12.2019 | LU | 22.04.2020 | FI | 22.04.2021 | HR | 22.04.2021 | IE | 22.04.2021 | LT | 22.04.2021 | LV | 22.04.2021 | HU | 23.04.2021 | SE | 23.04.2021 | SI | 23.04.2021 | BE | 30.04.2021 | DK | 30.04.2021 | EE | 30.04.2021 | NO | 30.04.2021 | BG | 31.10.2021 | AT | 22.04.2024 | CZ | 22.04.2024 | GB | 22.04.2024 | IT | 22.04.2024 | SK | 22.04.2024 | ES | 23.04.2024 | CH | 30.04.2024 | FR | 30.04.2024 | NL | 01.05.2024 | PT | 22.10.2024 | GR | 04.11.2024 | DE | 05.11.2024 | [2025/33] |
| Former [2025/23] | AL | 07.08.2019 | |
| CY | 07.08.2019 | ||
| MC | 07.08.2019 | ||
| MK | 07.08.2019 | ||
| MT | 07.08.2019 | ||
| RO | 07.08.2019 | ||
| RS | 07.08.2019 | ||
| SM | 07.08.2019 | ||
| TR | 07.08.2019 | ||
| IS | 07.12.2019 | ||
| LU | 22.04.2020 | ||
| FI | 22.04.2021 | ||
| HR | 22.04.2021 | ||
| IE | 22.04.2021 | ||
| LT | 22.04.2021 | ||
| LV | 22.04.2021 | ||
| HU | 23.04.2021 | ||
| SE | 23.04.2021 | ||
| SI | 23.04.2021 | ||
| BE | 30.04.2021 | ||
| DK | 30.04.2021 | ||
| EE | 30.04.2021 | ||
| NO | 30.04.2021 | ||
| BG | 31.10.2021 | ||
| AT | 22.04.2024 | ||
| CZ | 22.04.2024 | ||
| GB | 22.04.2024 | ||
| IT | 22.04.2024 | ||
| SK | 22.04.2024 | ||
| CH | 30.04.2024 | ||
| FR | 30.04.2024 | ||
| NL | 01.05.2024 | ||
| PT | 22.10.2024 | ||
| GR | 04.11.2024 | ||
| DE | 05.11.2024 | ||
| Former [2025/11] | AL | 07.08.2019 | |
| CY | 07.08.2019 | ||
| MC | 07.08.2019 | ||
| MK | 07.08.2019 | ||
| MT | 07.08.2019 | ||
| RO | 07.08.2019 | ||
| RS | 07.08.2019 | ||
| SM | 07.08.2019 | ||
| TR | 07.08.2019 | ||
| IS | 07.12.2019 | ||
| LU | 22.04.2020 | ||
| FI | 22.04.2021 | ||
| HR | 22.04.2021 | ||
| IE | 22.04.2021 | ||
| LT | 22.04.2021 | ||
| LV | 22.04.2021 | ||
| HU | 23.04.2021 | ||
| SE | 23.04.2021 | ||
| SI | 23.04.2021 | ||
| BE | 30.04.2021 | ||
| DK | 30.04.2021 | ||
| EE | 30.04.2021 | ||
| NO | 30.04.2021 | ||
| BG | 31.10.2021 | ||
| AT | 22.04.2024 | ||
| CZ | 22.04.2024 | ||
| GB | 22.04.2024 | ||
| SK | 22.04.2024 | ||
| CH | 30.04.2024 | ||
| FR | 30.04.2024 | ||
| NL | 01.05.2024 | ||
| PT | 22.10.2024 | ||
| GR | 04.11.2024 | ||
| DE | 05.11.2024 | ||
| Former [2025/10] | AL | 07.08.2019 | |
| CY | 07.08.2019 | ||
| MC | 07.08.2019 | ||
| MK | 07.08.2019 | ||
| MT | 07.08.2019 | ||
| RO | 07.08.2019 | ||
| RS | 07.08.2019 | ||
| SM | 07.08.2019 | ||
| TR | 07.08.2019 | ||
| IS | 07.12.2019 | ||
| LU | 22.04.2020 | ||
| FI | 22.04.2021 | ||
| HR | 22.04.2021 | ||
| IE | 22.04.2021 | ||
| LT | 22.04.2021 | ||
| LV | 22.04.2021 | ||
| HU | 23.04.2021 | ||
| SE | 23.04.2021 | ||
| SI | 23.04.2021 | ||
| BE | 30.04.2021 | ||
| DK | 30.04.2021 | ||
| EE | 30.04.2021 | ||
| NO | 30.04.2021 | ||
| BG | 31.10.2021 | ||
| AT | 22.04.2024 | ||
| CZ | 22.04.2024 | ||
| GB | 22.04.2024 | ||
| SK | 22.04.2024 | ||
| FR | 30.04.2024 | ||
| NL | 01.05.2024 | ||
| PT | 22.10.2024 | ||
| GR | 04.11.2024 | ||
| DE | 05.11.2024 | ||
| Former [2025/09] | AL | 07.08.2019 | |
| CY | 07.08.2019 | ||
| MC | 07.08.2019 | ||
| MK | 07.08.2019 | ||
| MT | 07.08.2019 | ||
| RO | 07.08.2019 | ||
| RS | 07.08.2019 | ||
| SM | 07.08.2019 | ||
| TR | 07.08.2019 | ||
| IS | 07.12.2019 | ||
| LU | 22.04.2020 | ||
| FI | 22.04.2021 | ||
| HR | 22.04.2021 | ||
| IE | 22.04.2021 | ||
| LT | 22.04.2021 | ||
| LV | 22.04.2021 | ||
| HU | 23.04.2021 | ||
| SE | 23.04.2021 | ||
| SI | 23.04.2021 | ||
| BE | 30.04.2021 | ||
| DK | 30.04.2021 | ||
| EE | 30.04.2021 | ||
| NO | 30.04.2021 | ||
| BG | 31.10.2021 | ||
| AT | 22.04.2024 | ||
| GB | 22.04.2024 | ||
| FR | 30.04.2024 | ||
| NL | 01.05.2024 | ||
| PT | 22.10.2024 | ||
| GR | 04.11.2024 | ||
| DE | 05.11.2024 | ||
| Former [2025/08] | AL | 07.08.2019 | |
| CY | 07.08.2019 | ||
| MC | 07.08.2019 | ||
| MK | 07.08.2019 | ||
| MT | 07.08.2019 | ||
| RO | 07.08.2019 | ||
| RS | 07.08.2019 | ||
| SM | 07.08.2019 | ||
| TR | 07.08.2019 | ||
| IS | 07.12.2019 | ||
| LU | 22.04.2020 | ||
| FI | 22.04.2021 | ||
| HR | 22.04.2021 | ||
| IE | 22.04.2021 | ||
| LT | 22.04.2021 | ||
| LV | 22.04.2021 | ||
| HU | 23.04.2021 | ||
| SE | 23.04.2021 | ||
| SI | 23.04.2021 | ||
| BE | 30.04.2021 | ||
| DK | 30.04.2021 | ||
| EE | 30.04.2021 | ||
| NO | 30.04.2021 | ||
| BG | 31.10.2021 | ||
| NL | 01.05.2024 | ||
| PT | 22.10.2024 | ||
| GR | 04.11.2024 | ||
| DE | 05.11.2024 | ||
| Former [2025/03] | AL | 07.08.2019 | |
| CY | 07.08.2019 | ||
| MC | 07.08.2019 | ||
| MK | 07.08.2019 | ||
| MT | 07.08.2019 | ||
| RO | 07.08.2019 | ||
| RS | 07.08.2019 | ||
| SM | 07.08.2019 | ||
| TR | 07.08.2019 | ||
| IS | 07.12.2019 | ||
| LU | 22.04.2020 | ||
| FI | 22.04.2021 | ||
| HR | 22.04.2021 | ||
| IE | 22.04.2021 | ||
| LT | 22.04.2021 | ||
| LV | 22.04.2021 | ||
| HU | 23.04.2021 | ||
| SE | 23.04.2021 | ||
| SI | 23.04.2021 | ||
| BE | 30.04.2021 | ||
| DK | 30.04.2021 | ||
| EE | 30.04.2021 | ||
| NO | 30.04.2021 | ||
| BG | 31.10.2021 | ||
| PT | 22.10.2024 | ||
| Former [2022/33] | AL | 07.08.2019 | |
| CY | 07.08.2019 | ||
| MC | 07.08.2019 | ||
| MK | 07.08.2019 | ||
| MT | 07.08.2019 | ||
| RO | 07.08.2019 | ||
| RS | 07.08.2019 | ||
| SM | 07.08.2019 | ||
| TR | 07.08.2019 | ||
| IS | 07.12.2019 | ||
| LU | 22.04.2020 | ||
| FI | 22.04.2021 | ||
| HR | 22.04.2021 | ||
| IE | 22.04.2021 | ||
| LT | 22.04.2021 | ||
| LV | 22.04.2021 | ||
| HU | 23.04.2021 | ||
| SE | 23.04.2021 | ||
| SI | 23.04.2021 | ||
| BE | 30.04.2021 | ||
| DK | 30.04.2021 | ||
| EE | 30.04.2021 | ||
| NO | 30.04.2021 | ||
| BG | 31.10.2021 | ||
| Former [2022/32] | AL | 07.08.2019 | |
| CY | 07.08.2019 | ||
| MC | 07.08.2019 | ||
| MK | 07.08.2019 | ||
| MT | 07.08.2019 | ||
| RO | 07.08.2019 | ||
| RS | 07.08.2019 | ||
| SM | 07.08.2019 | ||
| TR | 07.08.2019 | ||
| IS | 07.12.2019 | ||
| LU | 22.04.2020 | ||
| FI | 22.04.2021 | ||
| HR | 22.04.2021 | ||
| IE | 22.04.2021 | ||
| LT | 22.04.2021 | ||
| LV | 22.04.2021 | ||
| HU | 23.04.2021 | ||
| SE | 23.04.2021 | ||
| SI | 23.04.2021 | ||
| DK | 30.04.2021 | ||
| EE | 30.04.2021 | ||
| NO | 30.04.2021 | ||
| BG | 31.10.2021 | ||
| Former [2022/27] | AL | 07.08.2019 | |
| CY | 07.08.2019 | ||
| MC | 07.08.2019 | ||
| MT | 07.08.2019 | ||
| RO | 07.08.2019 | ||
| RS | 07.08.2019 | ||
| SM | 07.08.2019 | ||
| TR | 07.08.2019 | ||
| IS | 07.12.2019 | ||
| LU | 22.04.2020 | ||
| FI | 22.04.2021 | ||
| HR | 22.04.2021 | ||
| IE | 22.04.2021 | ||
| LT | 22.04.2021 | ||
| LV | 22.04.2021 | ||
| HU | 23.04.2021 | ||
| SE | 23.04.2021 | ||
| SI | 23.04.2021 | ||
| DK | 30.04.2021 | ||
| EE | 30.04.2021 | ||
| NO | 30.04.2021 | ||
| BG | 31.10.2021 | ||
| Former [2022/21] | AL | 07.08.2019 | |
| MC | 07.08.2019 | ||
| RO | 07.08.2019 | ||
| RS | 07.08.2019 | ||
| SM | 07.08.2019 | ||
| TR | 07.08.2019 | ||
| IS | 07.12.2019 | ||
| LU | 22.04.2020 | ||
| FI | 22.04.2021 | ||
| HR | 22.04.2021 | ||
| IE | 22.04.2021 | ||
| LT | 22.04.2021 | ||
| LV | 22.04.2021 | ||
| HU | 23.04.2021 | ||
| SE | 23.04.2021 | ||
| SI | 23.04.2021 | ||
| DK | 30.04.2021 | ||
| EE | 30.04.2021 | ||
| NO | 30.04.2021 | ||
| BG | 31.10.2021 | ||
| Former [2022/11] | AL | 07.08.2019 | |
| MC | 07.08.2019 | ||
| RO | 07.08.2019 | ||
| RS | 07.08.2019 | ||
| SM | 07.08.2019 | ||
| TR | 07.08.2019 | ||
| IS | 07.12.2019 | ||
| LU | 22.04.2020 | ||
| FI | 22.04.2021 | ||
| HR | 22.04.2021 | ||
| LT | 22.04.2021 | ||
| LV | 22.04.2021 | ||
| HU | 23.04.2021 | ||
| SE | 23.04.2021 | ||
| SI | 23.04.2021 | ||
| EE | 30.04.2021 | ||
| NO | 30.04.2021 | ||
| BG | 31.10.2021 | ||
| Former [2022/09] | AL | 07.08.2019 | |
| MC | 07.08.2019 | ||
| RO | 07.08.2019 | ||
| RS | 07.08.2019 | ||
| SM | 07.08.2019 | ||
| TR | 07.08.2019 | ||
| IS | 07.12.2019 | ||
| LU | 22.04.2020 | ||
| FI | 22.04.2021 | ||
| LT | 22.04.2021 | ||
| HU | 23.04.2021 | ||
| SE | 23.04.2021 | ||
| NO | 30.04.2021 | ||
| BG | 31.10.2021 | ||
| Former [2022/08] | AL | 07.08.2019 | |
| MC | 07.08.2019 | ||
| RO | 07.08.2019 | ||
| RS | 07.08.2019 | ||
| SM | 07.08.2019 | ||
| TR | 07.08.2019 | ||
| IS | 07.12.2019 | ||
| LU | 22.04.2020 | ||
| FI | 22.04.2021 | ||
| LT | 22.04.2021 | ||
| SE | 23.04.2021 | ||
| NO | 30.04.2021 | ||
| BG | 31.10.2021 | ||
| Former [2022/07] | AL | 07.08.2019 | |
| MC | 07.08.2019 | ||
| RO | 07.08.2019 | ||
| RS | 07.08.2019 | ||
| SM | 07.08.2019 | ||
| TR | 07.08.2019 | ||
| IS | 07.12.2019 | ||
| LU | 22.04.2020 | ||
| LT | 22.04.2021 | ||
| NO | 30.04.2021 | ||
| Former [2021/08] | AL | 07.08.2019 | |
| MC | 07.08.2019 | ||
| RO | 07.08.2019 | ||
| RS | 07.08.2019 | ||
| SM | 07.08.2019 | ||
| TR | 07.08.2019 | ||
| IS | 07.12.2019 | ||
| LU | 22.04.2020 | ||
| Former [2020/52] | AL | 07.08.2019 | |
| MC | 07.08.2019 | ||
| RO | 07.08.2019 | ||
| RS | 07.08.2019 | ||
| SM | 07.08.2019 | ||
| TR | 07.08.2019 | ||
| IS | 07.12.2019 | ||
| Former [2020/36] | AL | 07.08.2019 | |
| RO | 07.08.2019 | ||
| RS | 07.08.2019 | ||
| SM | 07.08.2019 | ||
| TR | 07.08.2019 | ||
| IS | 07.12.2019 | ||
| Former [2020/28] | AL | 07.08.2019 | |
| RO | 07.08.2019 | ||
| RS | 07.08.2019 | ||
| SM | 07.08.2019 | ||
| TR | 07.08.2019 | ||
| IS | 24.02.2020 | ||
| Former [2020/24] | AL | 07.08.2019 | |
| RO | 07.08.2019 | ||
| RS | 07.08.2019 | ||
| TR | 07.08.2019 | ||
| IS | 24.02.2020 | ||
| Former [2020/23] | AL | 07.08.2019 | |
| RO | 07.08.2019 | ||
| RS | 07.08.2019 | ||
| TR | 07.08.2019 | ||
| IS | 07.12.2019 | ||
| Former [2020/17] | AL | 07.08.2019 | |
| RS | 07.08.2019 | ||
| TR | 07.08.2019 | ||
| IS | 07.12.2019 | ||
| Former [2020/15] | AL | 07.08.2019 | |
| RS | 07.08.2019 | ||
| IS | 07.12.2019 | ||
| Former [2020/13] | RS | 07.08.2019 | |
| IS | 07.12.2019 | Cited in | International search | [XI] WO2007064222 (PHARMALOGICA AS et al.) | [A] WO2004075647 (BIOLI INNOVATION AS et al.) | [A] WO2009120091 (PHARMALOGICA AS et al.) | by applicant | NO324262 | WELSCH, CW, CANCER RES., vol. 52, 1992, pages 2040S - 2048S | GLEISSMAN H. ET AL., EXPERIMENTAL CELL RESEARCH, vol. 316, 2010, pages 1365 - 1373 | TSENG, H. C. ET AL.: "Increased lysis of stem cells but not their differentiated cells by natural killer cells; de-differentiation or reprogramming activates NK cells", PLOS ONE, vol. 5, no. 7, 2010, pages EL 1590 | Opposition | NO20130552 | WO2014175748 | WO2009120091 | WO03063793 | WO2007064222 | "Oxidation in Omega-3 Oils: An Overview", A WHITE PAPER PREPARED BY THE GLOBAL ORGANIZATION FOR EPA AND DHA OMEGA-3S AND THE COUNCIL FOR RESPONSIBLE NUTRITION, 1 January 2018 (2018-01-01), pages 1 - 7, XP055457336, Retrieved from the Internet | NITURE, REFAI LUBNA: "PLANT PECTIN: A POTENTIAL SOURCE FOR CANCER SUPPRESSION", AMERICAN JOURNAL OF PHARMACOLOGY AND TOXICOLOGY, vol. 8, no. 1, 1 January 2013 (2013-01-01), pages 9 - 19, XP093007614, ISSN: 1557-4962, DOI: 10.3844/ajptsp.2013.9.19 DOI: http://dx.doi.org/10.3844/ajptsp.2013.9.19 | SWAMI SHRIKANT BASLINGAPPA, THAKOR N. J., HALDANKAR P. M., KALSE S. B.: "Jackfruit and Its Many Functional Components as Related to Human Health: A Review", COMPREHENSIVE REVIEWS IN FOOD SCIENCE AND FOOD SAFETY, vol. 11, no. 6, 1 November 2012 (2012-11-01), US , pages 565 - 576, XP055904399, ISSN: 1541-4337, DOI: 10.1111/j.1541-4337.2012.00210.x DOI: http://dx.doi.org/10.1111/j.1541-4337.2012.00210.x | NGO SUONG N. T., WILLIAMS DESMOND B., HEAD RICHARD J.: "Rosemary and Cancer Prevention: Preclinical Perspectives", CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION, vol. 51, no. 10, 1 December 2011 (2011-12-01), USA , pages 946 - 954, XP093007633, ISSN: 1040-8398, DOI: 10.1080/10408398.2010.490883 DOI: http://dx.doi.org/10.1080/10408398.2010.490883 | DAVOODI H., ESMAEILI S., MORTAZAVIAN A.M.: "Effects of Milk and Milk Products Consumption on Cancer: A Review : Dairy products and cancer", COMPREHENSIVE REVIEWS IN FOOD SCIENCE AND FOOD SAFETY, vol. 12, no. 3, 1 May 2013 (2013-05-01), US , pages 249 - 264, XP093007636, ISSN: 1541-4337, DOI: 10.1111/1541-4337.12011 DOI: http://dx.doi.org/10.1111/1541-4337.12011 | YANG C ET AL.: "Does Vitamin E Prevent or Promote Cancer?", CANCER PREV RES (PHILA, vol. 5, no. 5, May 2012 (2012-05-01), pages 701 - 705, XP055459345, DOI: 10.1158/1940-6207.CAPR-12-0045 DOI: http://dx.doi.org/10.1158/1940-6207.CAPR-12-0045 | FLEET C ET AL.: "Vitamin D and Cancer: A review of molecular mechanisms", BIOCHEM J., vol. 441, no. 1, 1 January 2012 (2012-01-01), pages 61 - 76 | KLLENBERG D ET AL.: "Health effects of dietary phospholipids", LIPIDS IN HEALTH AND DISEASE, vol. 11, 2012, pages 3, XP021118594, DOI: 10.1186/1476-511X-11-3 DOI: http://dx.doi.org/10.1186/1476-511X-11-3 | FERLAY J., STELIAROVA-FOUCHER E., LORTET-TIEULENT J., ROSSO S., COEBERGH J.W.W., COMBER H., FORMAN D., BRAY F.: "Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012", EUROPEAN JOURNAL OF CANCER, vol. 49, no. 6, 1 April 2013 (2013-04-01), Amsterdam NL , pages 1374 - 1403, XP093007659, ISSN: 0959-8049, DOI: 10.1016/j.ejca.2012.12.027 DOI: http://dx.doi.org/10.1016/j.ejca.2012.12.027 | ANONYMOUS: "Spis smart ved kreft", 23 November 2013 (2013-11-23), XP093007670, Retrieved from the Internet | "Smartfish Nutrifriend 1100 - jackfruit and lychee flavouring", DATASHEET, 21 October 2010 (2010-10-21), XP093007679 | "Smartfish Nutifriend 1100", DATASHEET, 30 May 2012 (2012-05-30), XP093007680 | ANONYMOUS: "Smartfish Norway Nutrifriend 1100 | You Will Understand", 10 October 2012 (2012-10-10), XP093007681, Retrieved from the Internet | CATTLEY RUSSELL C., RADINSKY BERT R.: "Cancer Therapeutics: Understanding the Mechanism of Action", TOXICOLOGIC PATHOLOGY, vol. 32, no. 1_suppl, 1 January 2004 (2004-01-01), US , pages 116 - 121, XP093007683, ISSN: 0192-6233, DOI: 10.1080/01926230490426507 DOI: http://dx.doi.org/10.1080/01926230490426507 |